Correlation Between ARCA Biopharma and RenovoRx

Can any of the company-specific risk be diversified away by investing in both ARCA Biopharma and RenovoRx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ARCA Biopharma and RenovoRx into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between ARCA Biopharma and RenovoRx, you can compare the effects of market volatilities on ARCA Biopharma and RenovoRx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ARCA Biopharma with a short position of RenovoRx. Check out your portfolio center. Please also check ongoing floating volatility patterns of ARCA Biopharma and RenovoRx.

Diversification Opportunities for ARCA Biopharma and RenovoRx

-0.17

Correlation Coefficient

ARCA Biopharma  RenovoRx

Good diversification

The 3 months correlation between ARCA and RenovoRx is -0.17. Overlapping area represents the amount of risk that can be diversified away by holding ARCA Biopharma and RenovoRx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on RenovoRx and ARCA Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ARCA Biopharma are associated (or correlated) with RenovoRx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of RenovoRx has no effect on the direction of ARCA Biopharma i.e., ARCA Biopharma and RenovoRx go up and down completely randomly.

Pair Corralation between ARCA Biopharma and RenovoRx

Given the investment horizon of 90 days ARCA Biopharma is expected to generate 1.01 times less return on investment than RenovoRx. But when comparing it to its historical volatility, ARCA Biopharma is 1.66 times less risky than RenovoRx. It trades about 0.04 of its potential returns per unit of risk. RenovoRx is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  198.00  in RenovoRx on April 2, 2024 and sell it today you would lose (83.00) from holding RenovoRx or give up 41.92% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

ARCA Biopharma  vs.  RenovoRx

ARCA Biopharma

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in ARCA Biopharma are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady forward indicators, ARCA Biopharma displayed solid returns over the last few months and may actually be approaching a breakup point.

RenovoRx

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days RenovoRx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, RenovoRx is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with ARCA Biopharma and RenovoRx

The main advantage of trading using opposite ARCA Biopharma and RenovoRx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ARCA Biopharma position performs unexpectedly, RenovoRx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in RenovoRx will offset losses from the drop in RenovoRx's long position.

The idea behind ARCA Biopharma and RenovoRx pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.